Stay updated on Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial

Sign up to get notified when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the primary efficacy endpoint of the study from baseline in the Eczema Area and Severity Index (EASI) total score at Day 29. This change reflects an adjustment in the comparison of crisaborole versus vehicle, with subjects from both Cohort 1 and Cohort 2 now included in the analysis.
    Difference
    0.1%
    Check dated 2024-06-06T14:11:33.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that researchers are looking for males and females aged 2 years and older diagnosed with mild to moderate atopic dermatitis. Previously, this section indicated that no information was provided about collaborators.
    Difference
    8%
    Check dated 2024-05-22T20:29:24.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:28:56.000Z thumbnail image

Stay in the know with updates to Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.